Latest news with #JohnsonAndJohnson
Yahoo
4 days ago
- Business
- Yahoo
3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row
Federal Realty has increased its dividend by a REIT-leading 57 straight years. Johnson & Johnson has hiked its dividend for 63 years in a row. PepsiCo recently extended its dividend growth streak to 53 consecutive years. 10 stocks we like better than Federal Realty Investment Trust › Some of the best dividend stocks in the world are on sale right now. Shares of Federal Realty Investment Trust (NYSE: FRT), Johnson & Johnson (NYSE: JNJ), and PepsiCo (NASDAQ: PEP) are currently down 8% to 27% from their 52-week highs. Those sell-offs have pushed their dividend yields even higher. With elite records of dividend growth -- each has delivered more than 50 years of consecutive annual payment increases -- they are very attractive investment opportunities right now. Shares of Federal Realty Investment Trust have declined nearly 20% from their 52-week high. That slump has pushed the real estate investment trust's (REIT) dividend yield up to more than 4.5%. That's over three times higher than the S&P 500's sub-1.5% dividend yield. Federal Realty has increased its dividend for 57 straight years. That's the longest record in the REIT industry. It qualifies the company for the elite group of Dividend Kings, companies with 50 or more years of increasing their dividend payments. A big factor driving the REIT's consistent growth is its focus on quality over quantity. It has a concentrated portfolio of high-quality retail-based properties in strategically selected metro markets, primarily major cities along the coasts. It focuses on owning open-air shopping centers and mixed-use properties in first-ring suburban locations because they have a high density of high-income consumers. That makes its properties highly attractive to retailers, driving high occupancy levels and steady rent growth. Federal Realty routinely invests capital to enhance its portfolio by redeveloping existing properties or acquiring higher-quality properties, often funding these investments by selling lower-quality locations. Shares of healthcare giant Johnson & Johnson have shed more than 8% of their value from their recent peak. That has helped nudge the company's dividend yield up to nearly 3.5%. The company also increased its dividend payment by 4.8% earlier this year, extending its growth streak to 63 consecutive years. Johnson & Johnson is arguably the healthiest high-yielding dividend stock in the world. The company has a pristine AAA credit rating, higher than the U.S. government. It backs that elite bond rating with a strong balance sheet and robust free cash flow. The company ended the first quarter with only $13.5 billion of net debt, or $38.8 billion of cash and $52.3 billion of debt. That's a small amount considering its nearly $370 billion market cap. The healthcare company also generates about $20 billion in free cash flow each year, even though it's one of the world's top investors in research and development (R&D) at over $17 billion last year. It produces more than enough cash to cover its nearly $12 billion annual dividend outlay. The company's heavy investments in R&D and inorganic spending, totaling over $30 billion in acquisitions and other external investments over the past few quarters, should drive continued earnings growth. That puts Johnson & Johnson in a strong position to continue increasing its payout. PepsiCo's stock has gotten walloped, falling more than 27% from its 52-week high. One benefit of that sell-off is that the beverage and snacking giant's dividend yield has risen well past 4%. The company also recently hiked its payout by another 5%, extending its dividend growth streak to 53 straight years. The company produces a lot of cash, which enables it to invest in growing its business and pay its lucrative dividend. It spends money to develop innovative products, increase manufacturing capacity, and improve productivity. PepsiCo expects these investments to drive 4% to 6% annual organic revenue growth and high single-digit annual earnings-per-share growth. On top of that, the company has a strong balance sheet, which enables it to make strategic acquisitions to enhance its growth. PepsiCo recently closed its $1.7 billion purchase of Poppi as part of its ongoing portfolio transformation toward healthier products. The company's growth investments should give it plenty of pop to continue boosting its shareholder payout. Federal Realty, Johnson & Johnson, and PepsiCo are among the dividend elite by raising their payouts for more than 50 straight years. With their share prices down and yields up, they look like very attractive investment opportunities right now. Income-focused investors can lock in a higher-yielding income stream that should continue growing in the decades ahead. Before you buy stock in Federal Realty Investment Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Federal Realty Investment Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,389!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $830,492!* Now, it's worth noting Stock Advisor's total average return is 982% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Matt DiLallo has positions in Johnson & Johnson and PepsiCo. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy. 3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
4 days ago
- Business
- Forbes
Was James Lewis The Tylenol Killer? The Chilling True Story Behind Netflix's Docuseries
Cold Case: The Tylenol Murders Four decades after the Tylenol murders caused mass panic in Chicago and across the country, Netflix's new docuseries Cold Case: The Tylenol Murders is revisiting the unsolved case. What happened in one of the largest criminal investigations in U.S. history, and why has justice never been served? In 1982, seven people in the Chicago area died under the same mysterious circumstances: they had all taken Extra-Strength Tylenol. After testing, each of the capsules was found to be laced with potassium cyanide at toxic levels high enough to provide 'thousands of fatal doses,' Time Magazine reported. News of the poisoned capsules sparked fear among the six million residents of the Chicago area. Health officials quickly advised the public to stop using the over-the-counter medication, and authorities went door-to-door warning residents of the potential danger. From directors Yotam Guendelman and Ari Pines, Cold Case: The Tylenol Murders dives into the 'shocking theories and evidence, looks at new testimonies, and even gets inside the mind of a key suspect,' according to Netflix's Tudum. Read on for a deeper dive into the Tylenol Murders, including who the victims were, the main person of interest James Lewis, and what happened to Johnson & Johnson during the investigation. Cold Case: The Tylenol Murders The first victim was 12-year-old Mary Kellerman, whose parents gave her Tylenol after she complained of a cold. She died just hours later. Postal worker Adam Janus died later that morning after taking the pills for chest pain. While mourning his death, Adam's brother, Stanley, and Stanley's wife, Theresa, who were both suffering from headaches, also took Tylenol and died later that day. Another victim was 27-year-old Mary Reiner, who had just returned home after giving birth to her first child. Paula Prince, a 35-year-old United Airlines flight attendant, was also found dead in her apartment with an open Tylenol bottle nearby. Paramedics said there was so much cyanide on her lips that anyone who tried to resuscitate her might have been poisoned as well. The seventh victim was 31-year-old Mary McFarland of Elmhurst, who collapsed at work after taking Tylenol for a headache. A pathologist's test found cyanide in her blood, the New York Times reported at the time. The Netflix documentary notes that there could be more victims, as cyanide tests are rarely included in a standard autopsy toxicology screen unless there is a specific reason to suspect poisoning. For example, if an elderly person had ingested cyanide, the cause of death might have been harder to detect. American businessman and CEO of Johnson and Johnson, James Burke, New Brunswick, New Jersey, 1981. ... More (Photo by Brownie Harris/Corbis via Getty Images) In the early days of the investigation, Johnson & Johnson executives feared they might bear some responsibility for the murders, according to the Netflix docuseries. At the time, Tylenol was the pharmaceutical company's most profitable product. Illinois Attorney General Tyrone Fahner, who was interviewed in the series, recalled telling Johnson & Johnson to stop selling Tylenol – prompting what would become the largest product recall in history. While testing the contents of the Tylenol bottles, investigators noticed that some capsules had brown rings forming at the ends, evidence of cyanide corrosion. It became clear that the capsules had been pulled apart, emptied of their medicine, and refilled with cyanide. It was also revealed that the contaminated pills came from two different manufacturing plants, one in suburban Philadelphia and the other in Texas. After both facilities showed no evidence of cyanide tampering, investigators began to suspect that someone had tampered with the capsules after they reached store shelves. The tainted Tylenol bottles had been sold at various drugstores across the Chicago area. Cold Case: The Tylenol Murders Police had no major investigative leads, no connections between the victims, no witnesses, and no clear motive until October 6, 1982. Seven days after the murders, Johnson & Johnson received an extortion letter threatening that more people would be poisoned if certain demands were not met. The letter demanded that $1 million be deposited into an account at Chicago's Continental Bank or a second wave of killings would follow. Investigators believed the person who wrote the letter was likely involved, as he demonstrated specific knowledge about poison and how it works. The bank account was linked to a travel agency called Lakeside Travel, owned by Fred Miller McCahey, a wealthy businessman. McCahey told authorities he had recently gotten into a dispute with a volatile man named Robert Richardson, the husband of one of his employees, Nancy Richardson. Employees at the travel agency noted that the handwriting on the extortion letter resembled Robert's. Handwriting experts later confirmed that it was identical. After Robert and Nancy fled, authorities attempted to track him down using a photo published alongside an article he had written for the Chicago Tribune. Investigators also noted that he resembled the man seen in surveillance footage from the store where Mary McFarland had purchased the lethal Tylenol, per Cold Case. James Lewis in "Cold Case: The Tylenol Murders." David Barton, a former sergeant with the Kansas City, Missouri Police Department, recalled seeing a photo of Richardson on the news and immediately sensing something was off. 'I looked at the picture, and I immediately recognized him, jumped up off the couch and said, 'Goddam it, that's not Robert Richardson,'' Barton told Netflix. 'That's not Robert Richardson… that's James Lewis.' Lewis, a tax consultant, became the police's prime suspect in the Tylenol murders. He also had a criminal history. In 1978, Lewis was charged with murder in Kansas City after police discovered the dismembered remains of one of his former clients, Raymond West, in bags in his attic. Authorities also found a forged check that Lewis tried to cash from West's account. However, charges were dropped after a judge ruled that the search of Lewis' home was illegal, according to In 2004, he was charged with rape and kidnapping, but the case was dropped. Lewis was interviewed for Netflix's docuseries, where he denied any involvement in the crimes. "They make it look like I'm the world's most horrible, dangerous person ever... and I wouldn't hurt anybody," Lewis said. Lewis was convicted of extortion for the letter and spent more than 12 years in federal prison. 'I did not consider it an extortion letter because I did not actually have access to making any money from that letter,' he told Netflix. Although officials found drafts of extortion letters in James Lewis's home, along with a book about poisonings, tying him directly to the Tylenol murders was difficult. He was never charged with the killings because authorities could not confirm that he was in the Chicago area during the murders. He had reportedly taken an Amtrak train to New York City and was staying in a hotel there, but police couldn't prove that he returned to Chicago. The FBI reopened the investigation in early 2009 and continued to focus on Lewis. They searched his office in Cambridge, Massachusetts, as well as a nearby storage unit he had rented. According to CBS News, in September 2022, members of the task force returned to Boston to re-interview him. Lewis passed away in 2023. IRVINE, CALIFORNIA - OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on ... More October 17, 2023 in Irvine, California. Johnson & Johnson beat Wall Street's quarterly revenue and earnings estimates as sales in its pharmaceutical and medical devices businesses grew. (Photo by) Johnson & Johnson has denied that there was any chance their pills could have been tampered with at their factories, claiming that no cyanide was used in their facilities. However, as the documentary reveals, that turned out to be false. 'Cyanide is present and is used in crucial tests of the Tylenol,' former New York Times pharmaceutical reporter Gardiner Harris said in the series. He also pointed out that the company did most of the investigating themselves, even though they seemed to have 'every season to hide the extent of the contamination problems.' The documentary reveals that potassium cyanide was used it a quality control tests of Tylenol and was found in the vicinity of where the pills were assembled. In 1988, a court ruled that Johnson & Johnson wasn't liable for Diane Elsroth's death. The families of the Chicago victims also sued the company in 1983, claiming that the Johnson & Johnson knew that their bottles ould be tampered with. Johnson & Johnson settled the suit in 1991 and agreed to pay an undisclosed sum without admitting liability. "Though there is no way we could have anticipated a criminal tampering with our product or prevented it, we wanted to do something for the families and finally get this tragic event behind us," Robert Kniffin, a spokesman for Johnson & Johnson, said at the time. Bruce Pfaff, a lawyer for the plaintiffs, called the agreement 'a very favorable settlement for my clients.' Several of the families were seeking between $10 million and $15 million for wrongful death, pain and suffering, and funeral expenses, according to The New York Times. A worker checks the newly implemented safety seals on Tylenol bottles shortly after the company's ... More re-release of Tylenol capsules in 1982. A few months earlier, a Chicago man poisoned Tylenol with cyanide, killing several people. | Location: Fort Washington, Pennsylvania, USA. (Photo by �� Leif Skoogfors/CORBIS/Corbis via Getty Images) Johnson & Johnson was ultimately able to successfully re-launch Tylenol after the scare. The company overhauled its manufacturing process and introduced three separate safety seals to Tylenol packaging. First was an outer box with glued flaps. Second, a tight plastic neck seal covering the cap and neck of the bottle. And finally, a strong inner foil seal placed over the mouth of the bottle. Four years after the original murders, on February 8, 1986, Diane Elsroth of Yonkers, New York, died after taking Extra-Strength Tylenol capsules that were found to contain cyanide, even though the bottle had a triple safety seal. Johnson & Johnson claimed at the time that someone had penetrated all the seals, resecured them, and returned the bottles to the shelf. The Netflix documentary reported that two additional triple-sealed bottles of Tylenol were also found to contain the poison. Ultimately, the Westchester District Attorney was able to determine where the pills had been tampered with. In the aftermath of the Tylenol poisonings, other pharmaceutical and food companies began implementing tamper-proof seals and safety indicators during the manufacturing process. These changes significantly reduced the number of copycat incidents. 'Before 1982, nobody thought twice about opening a bottle of painkillers,' Guendelman and Pines told Tudum. 'Today, every tamper-proof seal is a reminder of that dark moment — when cyanide-laced capsules transformed an everyday medicine into a murder weapon, permanently reshaping consumer industries." Watch the official trailer for Cold Case: The Tylenol Murders below.
Associated Press
6 days ago
- Business
- Associated Press
Jessica Dean Named to National Law Journal's 2025 Elite Women of the Plaintiffs Bar
DALLAS--(BUSINESS WIRE)--May 27, 2025-- Premier plaintiffs firm Dean Omar Branham Shirley, LLP, is proud to announce that partner Jessica Dean has been named to The National Law Journal's 2025 Elite Women of the Plaintiffs Bar, honoring women lawyers who have achieved exceptional results in high-stakes litigation on behalf of plaintiffs. 'I'm truly honored by this recognition,' said Ms. Dean. 'I care deeply about my clients and so appreciate the nod towards my life's work.' Ms. Dean has built a national reputation for holding powerful corporations accountable, with a primary focus in recent years on litigation against Johnson & Johnson (NYSE: JNJ). Her work has secured millions of dollars in compensation for victims and families of those who have lost loved ones. 'I'm proud to work alongside Jessica,' said firm partner Trey Branham . 'This honor is well-deserved and reflects her tireless advocacy.' Ms. Dean has secured life-changing verdicts for victims of corporate negligence and exposed systemic abuses that allow powerful entities to evade accountability. She and her firm secured several verdicts in 2024, including $45 million from a Chicago jury in the death of a mother of six, Theresa Garcia. This case, like many others, was mired in delays due to Johnson & Johnson's attempts to exploit the bankruptcy system to evade responsibility. Earlier this year, Ms. Dean earned national recognition from legal guide Lawdragon, which named her to its prestigious 500 Leading Lawyers in America and its 500 Leading Plaintiff Consumer Lawyers lists. The National Law Journal's Elite Trial Lawyers Awards honor firms and attorneys who have achieved significant results and showcased an unwavering commitment to advancing justice for their clients. View the other 2025 Elite Trial Lawyers honorees and finalists here. About Dean Omar Branham Shirley Dean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of the irresponsible conduct of others. For more information, please visit . View source version on CONTACT: Media Contact: BeLynn Hollers 800-559-4534 [email protected] KEYWORD: TEXAS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES SOURCE: Dean Omar Branham Shirley, LLP Copyright Business Wire 2025. PUB: 05/27/2025 10:07 AM/DISC: 05/27/2025 10:06 AM
The Review Geek
6 days ago
- Entertainment
- The Review Geek
Cold Case: The Tylenol Murders Review – Who poisoned the pills?
Season 1 Episode Guide Pain Killer The Bitter Pill Sealed For Your Protection Back in 1982, a case rocked the Chicago metropolitan area when seven people died after consuming tainted Tylenol tablets. Upon ingestion, the victims suffered seizures, foamed at the mouth, and subsequently passed away. When examined, the pills were found to be laced with potassium cyanide. This forms the backbone of Netflix's latest cold case docu-series, The Tylenol Murders. With very little to go on and the FBI desperate to crack the case, the three episodes examine the timeline from start to finish, delving into what happened, how it potentially occurred, and the public backlash that followed. Each episode explores a slightly different facet of the case. Episode 1 works as an overview, spotlighting Johnson & Johnson's reaction to their tainted product and the general consensus among police at the time. Episode 2 shifts focus to the prime suspect, James Lewis. A troubled man with a difficult upbringing, Lewis vehemently maintains his innocence — something he calmly reiterates in interview clips here. This chapter attempts to prove (or disprove) his involvement, highlighting the lack of concrete evidence tying him to the crime. The third and final episode closes out with a deeper dive into Johnson & Johnson's role, featuring revealing statements from officers on duty at the time, family members seeking justice, and a suggested FBI bias that leans toward a single narrative — even in the face of uncertainty. While this series doesn't offer definitive closure, The Tylenol Murders does a good job exploring many of the most prominent theories. There's strong insight into Lewis's background, though given the short runtime, some avenues — including alternate suspects — could have been given more attention. One glaring omission is any mention of Stella Nickell. For context, Nickell was sentenced to 90 years in prison for tampering with Excedrin capsules laced with cyanide — a case that closely mirrors the Tylenol poisonings. While it is strongly considered that she's a copycat killer, it still would have been nice to see that brought up here. What is captured well, however, is the raw bias within the FBI. Even in recent interviews, agents remain adamant that Lewis is their guy, despite the case against him being largely circumstantial. It's a striking insight into investigative tunnel vision, and hints strongly that this could have derailed the investigation from the very beginning, all thanks to one incriminating letter. Stylistically, the show weaves together a wide range of talking head interviews — from law enforcement to journalists to grieving families. The variety of voices keeps the narrative dynamic, even if the documentary doesn't quite go as deep as it could have. If there's one persistent gripe though, it comes from the music. The score often feels too upbeat and action-oriented, clashing with the grim, tragic nature of the case. A more subdued, somber composition might have elevated the atmosphere more, and once you notice it, it's hard to ignore. Ultimately, whether we'll ever truly know who was responsible for the tainted Tylenol is still up for debate. But Netflix's latest true-crime offering remains a compelling and worthwhile dive into one of America's most disturbing unsolved cases.
Yahoo
25-05-2025
- Business
- Yahoo
US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson's DARZALEX FASPRO
On May 20, Johnson & Johnson (NYSE:JNJ) announced that the FDA Oncologic Drugs Advisory Committee/ODAC voted 6-2 in favor of the benefit-risk profile of single-agent DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for treating adult patients with high-risk smoldering multiple myeloma (HR-SMM). This recommendation is a step towards potentially making DARZALEX FASPRO the first treatment to delay or prevent the progression of this condition to active multiple myeloma. A closeup of pills in a pharmacy, representing the high quality medications of the company. An application for this approval was submitted to the FDA in November 2024. Currently, there are no approved treatments specifically for HR-SMM. The ODAC's decision was based on data from the Phase 3 AQUILA study. This was a randomized and open-label trial that evaluated the efficacy and safety of DARZALEX FASPRO versus active monitoring in HR-SMM patients. Smoldering multiple myeloma is an asymptomatic intermediate stage of multiple myeloma. However, ~50% of patients with HR-SMM are likely to develop active disease within 2 to 3 years. The current standard of care for SMM is active monitoring, which can lead to therapeutic intervention only after the detection of end-organ damage. Multiple myeloma is a blood cancer affecting plasma cells in the bone marrow, and it remains incurable. DARZALEX FASPRO received US FDA approval in May 2020 and is currently approved for 9 indications in multiple myeloma, including 4 for frontline treatment. Johnson & Johnson (NYSE:JNJ) engages in the R&D, manufacture, and sale of various products in the healthcare field worldwide. In August 2012, Janssen Biotech Inc. (a subsidiary of Johnson & Johnson) and Genmab A/S entered a worldwide agreement, which granted Janssen an exclusive license to develop, manufacture, and commercialize daratumumab. This is the active ingredient in DARZALEX FASPRO. While we acknowledge the potential of JNJ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than JNJ and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
